4//SEC Filing
Herendeen Paul 4
Accession 0001127602-21-010166
CIK 0000885590other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 8:59 PM ET
Size
10.9 KB
Accession
0001127602-21-010166
Insider Transaction Report
Form 4
Herendeen Paul
EVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Share Units
2021-03-08−49,324→ 0 totalExp: 2021-03-07→ Common Stock (49,324 underlying) - Exercise/Conversion
Common Shares, No Par Value
2021-03-08+49,324→ 395,619 total - Award
Common Shares, No Par Value
2021-03-08+50,518→ 446,137 total - Tax Payment
Common Shares, No Par Value
2021-03-10$32.97/sh−59,519$1,962,341→ 386,618 total
Footnotes (5)
- [F1]Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018.
- [F2]Each PSU converts into Common Shares on a one-for-one basis
- [F3]This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs.
- [F4]The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics.
- [F5]This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 79,556 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date.
Documents
Issuer
Bausch Health Companies Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001374175
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 8:59 PM ET
- Size
- 10.9 KB